CompanyDrug

Mabwell Bioscience’s 9MW3011 Earns US FDA Fast Track Designation for Polycythemia Vera Treatment

CompanyMedical Device

Sansure Biotech Secures CE Mark for 60 Molecular Diagnostic Products, Including Procalcitonin Assay Kit

CompanyDeals

Abbott Expands Biosimilars Portfolio with mAbxience In-License Agreement

CompanyDeals

Merck Forges Partnerships with BenevolentAI and Exscientia for Precision Drug Discovery

CompanyDrug

Novartis’s Aimovig Approved by China’s NMPA for Preventive Migraines Treatment

CompanyDrug

Organon’s Liptruzet Approved in China for Hypercholesterolemia Treatment

Company

WuXi XDC Expands Manufacturing Capacity with New GMP Facilities in Wuxi

Policy / Regulatory

CDE Releases 74th Batch of Generic Reference Preparations with 58 New Specifications

CompanyDeals

Roche’s Genentech Partners with Peptidream for First-in-Class PDCs in Radioisotope Therapy

CompanyDeals

Lynk Pharmaceuticals Secures Series C2 Financing to Advance pipeline

CompanyDrug

Hainan Poly Pharm Submits DMF for Tecovirimat API to US FDA

CompanyLegal / IP

South Africa’s Competition Commission Investigates J&J for MDR-TB Drug Pricing and Evergreening